Background: Chronic Obstructive Pulmonary Diseases (COPD) is a common preventable and treatable disease characterized by persistent airflow limitation. TB is a serious public health problem causing immense morbidity, mortality and distress to individuals, families and communities. 

Methodology: In this study 100 consecutive subjects who had pulmonary TB in the past and had taken full course of anti-tubercular treatment and now coming with the complaint of one or more of cough, shortness of breath and expectoration were selected.

Results: 100 % of the patients presented with shortness of breath. About 78 % of the patients presented with cough and 56 % of the patients presented with expectoration. Near about 58 % of the patients presented with wheeze. Hemoptysis was present in 16 % of the patients and 31% of the patients presented with chest pain. Most of the 81 % of the patients had the duration of the symptoms less than 5 years.

Conclusion: There is a significant association between the severity of dyspnea and the COPD in post TB patients. There is a statistically proven association between the number of years before the pulmonary TB disease and the development of COPD. There is a statistically proven association between the duration of symptoms and the development of COPD.

Keywords: Chronic obstructive pulmonary disease, Tuberculosis, mMRC scale, spirometry.

1. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: http://goldcopd.org [Accessed on January 18, 2018]
2. Lopez AD, Rao SK, et al. Chronic obstructive pulmonary diseases: current burden and future projections. Eur Respire J 2006; 27: 397-412.
3. Mathers C D, Locar D. Projections of global mortality and burden of diseases from 2002 to 2030. PLoS med 2006; 3e 442.
4. Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D’Souza GA, Gupta D, et al. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci 2006; 48:23‑9.
5. Jindal SK, Aggarwal AN, Gupta D, Agarwal R, Kumar R, Kaur T, et al. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 2012; 16:1270‑7.
6. Baker DJ, Godfrey KM, Fall C, Osmond C, Winter PD. Relation with weight and childhood respiratory tract infection to adult Lung function and death from chronic obstructive pulmonary diseases. BMJ 1991; 303:671-5.
7. De Marco R, Accordini S, Marcon A et al. risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit care Med 2011; 183:891-7.
8. Hassan IS, Al-Jahdali HH. Obstructive airways disease in patients with significant post-tuberculous lung scarring. Saudi Med J 2005; 26:1155-7.
9. Bidwell JL et al. Hemoptysis: diagnosis and management. Am Fan Physician 2005; 72:1253-60.
10. Parma SP et al. epidemiology of hemoptysis. Indian J of Tuberculosis 1970; 17:111-8.
11. Sharma SK , Mohan A. pulmonary tuberculosis: typical and atypical cases. Case tract series1. Mumbai: marind 1997.Sodeman WA, Sodeman, TM. Pathologic physiology: mechanisms of disease. 7th ed. Philadelphia: PA. WB Saunders, 1985; 467.
12. Launois C, Barbe C, Bertin E, Nardi J, Perotin JM, Dury S, et al. The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study. BMC Pulm Med.2012 Oct 1;12:61. 
13. Baig IM, Saeed W, Khalil KF, et al. Post-Tuberculous Chronic Obstructive Pulmonary Disease.Journal of the College of Physicians and Surgeons Pakistan 2010; 20 (8): 542-544.
14. Menezes AMB, Hallal PC, Perez-Padilla R, Jardim JRM, Muin OA, Lopez MV, et al. Latin American Project for the investigation of obstructive lung disease (PLATINO) team. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J 2007; 30:1180-5. Epub 2007 Sep 5.
15. Jethani S, Kakkar R, Semwal J, Rawat J et al. Socio demographic profile of tuberculosis patient: a hospital based study at Dehradun. National Journal of Community Medicine Jan – Mar 2014; 5(1):6-9.
16. Ravi Kumar BP, Reddy Dudala S, Rao AR. Kuppuswamy’s socio-economic status scale –a revision of economic parameter for 2012. International Journal of Research & Development of Health Jan 2013;1(1): 2-4.
17. Verma R, Khanna P, Mehta B. Revised National Tuberculosis Control Program in India: The Need to Strengthen. International Journal of Preventive Medicine. 2013;4(1):1-5.
18. Sei Won Lee, Young Sam Kim, Dong-Soon Kim3, Yeon-Mok Oh, and Sang-Do LeeThe Risk of Obstructive Lung Disease by Previous Pulmonary Tuberculosis in a Country with Intermediate Burden of Tuberculosis. J Korean Med Sci 2011; 26: 268-27.
19. Hassan IS, Al-Jahdali HH. Obstructive airways disease in patients with significant post-tuberculous lung scarring. Saudi Med J 2005; 26:1155-7.
20. Aktogu S, Yorgancioglu A, Cirak K, et al. 1996. Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5,480 cases. Eur Respir J, 9:2031–5.
21. Verma SK, Narayan KV, Kumar Set al. A Study on Prevalence of Obstructive Airway Disease among Post Pulmonary Tuberculosis Patients. Pulmon 2009; 11(1): 4-7.
22. Hnizdo E, Singh T, Churchyard G, et al. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. Jan 2000; 55(1): 32–38.

Dr Sukanta Sen

Associate Professor, Department of Pharmacology,

ICARE Institute of Medical Sciences & Research, Haldia, West Bengal - 721645, India

Ph: +91- 8420532336 (M), Email: This email address is being protected from spambots. You need JavaScript enabled to view it.